-transparent.png){kind=logo}
After inoculation with viable BCG organisms, spleen cells from mice developed cellular immune reactivity to purified protein derivative antigen by day 10, which declined by day 25; after rechallenge on day 25, a vigorous secondary response rapidly developed (by day 29). The inclusion of autochthonous serum (from the BCG-infected mice) in the in vitro cellular immune reactivity tests altered this pattern considerably: the primary response was shortened, and the secondary response totally abated, suggesting the presence of blocking factors active against BCG-specific cellular immune reactivity in the sera of infected animals. Subsequent experiments indicated that BCG-specific serum blocking factor activity could be generated in the serum of control mice by the intravenous inoculation of purified protein derivative.
P G Holt, and
P J Fimmel, and
L M Roberts, and
D Keast
May 1978,
Infection and immunity,
P G Holt, and
P J Fimmel, and
L M Roberts, and
D Keast
May 1994,
Veterinary microbiology,
P G Holt, and
P J Fimmel, and
L M Roberts, and
D Keast
September 1980,
Tubercle,
P G Holt, and
P J Fimmel, and
L M Roberts, and
D Keast
April 1979,
Zhurnal mikrobiologii, epidemiologii i immunobiologii,
P G Holt, and
P J Fimmel, and
L M Roberts, and
D Keast
January 2013,
Clinical & developmental immunology,
P G Holt, and
P J Fimmel, and
L M Roberts, and
D Keast
February 1981,
Zhurnal mikrobiologii, epidemiologii i immunobiologii,
P G Holt, and
P J Fimmel, and
L M Roberts, and
D Keast
September 1968,
Nature,
P G Holt, and
P J Fimmel, and
L M Roberts, and
D Keast
August 1984,
Journal of immunology (Baltimore, Md. : 1950),
P G Holt, and
P J Fimmel, and
L M Roberts, and
D Keast
October 1998,
Acta medica portuguesa,
P G Holt, and
P J Fimmel, and
L M Roberts, and
D Keast
January 1997,
Transactions of the Royal Society of Tropical Medicine and Hygiene,
